Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
250 hedge funds and large institutions have $3.3B invested in Inari Medical, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 98 increasing their positions, 89 reducing their positions, and 29 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 89
10% more capital invested
Capital invested by funds: $3B → $3.3B (+$301M)
7% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 29
0% more funds holding
Funds holding: 249 → 250 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
70% less call options, than puts
Call options by funds: $10.3M | Put options by funds: $34.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$17.6M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
+$16.2M |
| 3 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$13.7M |
| 4 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$13.7M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$12.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$39.1M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$28M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$28M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$23.5M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$19M |
NARI Hedge Fund Activity: Q3 2023 in Review
250 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q3 2023, worth a combined $3.3B — up 10% from $3B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new NARI positions and 29 closed out — a net gain of 2 holders — while 98 added to existing stakes and 89 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $17.6M. The largest seller was Goldman Sachs, cutting an estimated $39.1M.
- 250 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q3 2023, up from 249 in Q2 2023.
- Funds reported $3.3B of Inari Medical, Inc. Common Stock stock for Q3 2023, up 10% quarter-over-quarter.
- 31 funds opened new Inari Medical, Inc. Common Stock positions in Q3 2023 and 29 closed out, a net change of +2 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q3 2023 was JP Morgan Chase, an estimated $17.6M added.
- The largest Inari Medical, Inc. Common Stock seller in Q3 2023 was Goldman Sachs, an estimated $39.1M sold.
Based on aggregated 13F filings for Q3 2023.